Centene's results for Q3 2026 (quarter ended September 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-27. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $50,647 million (+1.9% vs a year earlier) |
| Diluted EPS (GAAP) | $-0.14 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $0.58 |
| Full-year guidance | Raised |
Guidance
Centene raised its 2026 adjusted EPS guidance by $0.40 to more than $5.20 and GAAP EPS to more than $3.46, and lowered its HBR range.
Why this label: 'Increases 2026 full year adjusted diluted EPS guidance by $0.40' (floor >$5.20); GAAP EPS floor also increased; revenue direction not stated.
| Metric | Period | New | Prior (as stated in the release) |
|---|---|---|---|
| adjusted diluted EPS | FY2026 | greater than $5.20 | not stated |
| GAAP diluted EPS | FY2026 | greater than $3.46 | not stated |
| health benefits ratio (HBR) | FY2026 | 90.4% to 91.1% | not stated |
| interest expense | FY2026 | $600 million to $620 million | not stated |
| total revenues | FY2026 | $196.5 to $200.5 billion | not stated |
From the release
Revenue: "Total revenues · 50,647 · 49,690 · 154,170 · 145,052"
Earnings per share: "-- Third Quarter GAAP Diluted Loss Per Share of $(0.14); Adjusted Diluted Earnings Per Share of $0.58 --"
adjusted diluted EPS: "Increases 2026 full year adjusted diluted EPS guidance by $0.40."
GAAP diluted EPS: "-- Increases 2026 GAAP Diluted EPS Guidance: Greater than $3.46 & Adjusted Diluted EPS Greater than $5.20 --"
health benefits ratio (HBR): "Additionally, the Company is decreasing its HBR guidance range to 90.4% to 91.1% and its interest expense guidance range to $600 million to $620 million."
Quotes are copied from the filing; in table rows, cell borders are shown as “·”.
Key fact: Centene raised 2026 adjusted EPS guidance by $0.40 to greater than $5.20
Source
Centene earnings release (SEC filing), accession 0001071739-26-000194, filed 2026-10-27.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.